Skip to content
MedsAcross

Medicine

Glatopa 40 mg/1 mL injection

Glatiramer · Subcutaneous · Sandoz
Available on requestPrescription onlyUS FDA Cold chain

Glatopa 40 mg/1 mL injection is a prescription medicine containing Glatiramer for subcutaneous use, marketed by Sandoz, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Cold chain

Store Glatopa refrigerated at 2°C to 8°C (36°F to 46°F). Do not freeze…

Key facts

Active ingredient (INN)
Glatiramer
Brand
Glatopa
Strength
40 mg/1 mL
Dosage form
Injection
Route
Subcutaneous
Packs
12 blister pack of 1 mL
Marketing authorisation holder
Sandoz
Manufacturers
SandozBryant Ranch Prepack
Origin register
US FDA, United States
Storage
Store Glatopa refrigerated at 2°C to 8°C (36°F to 46°F). Do not freeze Glatopa. If a Glatopa syringe freezes, it should be discarded. If needed, the patient may store Glatopa at room temperature, 15°C to 30°C (59°F to 86°F), for up to one month, but refrigeration is preferred.
Cold chain
Yes, shipped temperature controlled
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
12 February 2018
Identifiers
RxCUI 1487361, 2000007, 1111641 +1DailyMed set ID 028fdf0e-2340-407b-bcd8-5a99accdddbf, 5f01e40a-b6f6-40fb-b37c-3d06f1428e86NDC 63629-8816, 0781-3250Application ANDA206921

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

PackCodeLabelerMarketed since
12 blister pack in 1 carton / 1 syringe, glass in 1 blister pack / 1 mL in 1 syringe, glass0781-3250-89Sandoz12 February 2018
12 blister pack in 1 carton / 1 syringe, glass in 1 blister pack / 1 mL in 1 syringe, glass63629-8816-1Bryant Ranch Prepack10 September 2021

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 20 December 1996Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Glatiramer 40 mg/1 mL injection.

Compare all 2

Other strengths and forms of Glatiramer

Clinical summary

Glatiramer is a prescription medicine indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. MedsAcross supplies Glatiramer for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Glatiramer

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Glatopa 40 mg/1 mL injection for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.